Cargando…
The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study
BACKGROUND/AIM: We aimed to evaluate the efficacy of fulvestrant and its affecting clinical factors, including the optimal sequencing of fulvestrant and chemotherapy in a real-life cohort. METHODS: The data of 256 metastatic hormone-positive breast cancer patients treated with fulvestrant were evalu...
Autores principales: | GÜVEN, Deniz Can, YILDIRIM, Hasan Çağrı, ERUL, Enes, ŞAHİN, Taha Koray, ÇAKIR, İbrahim Yahya, AKTEPE, Oktay Halit, KERTMEN, Neyran, DİZDAR, Ömer, AKSOY, Sercan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395701/ https://www.ncbi.nlm.nih.gov/pubmed/36422490 http://dx.doi.org/10.55730/1300-0144.5495 |
Ejemplares similares
-
The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy
por: Guven, Deniz Can, et al.
Publicado: (2022) -
Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19
por: Guven, Deniz Can, et al.
Publicado: (2020) -
The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis
por: Guven, Deniz Can, et al.
Publicado: (2022) -
Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer †
por: Yekedüz, Emre, et al.
Publicado: (2022) -
The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
por: Guven, Deniz Can, et al.
Publicado: (2022)